{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:44:53Z","timestamp":1792719893641,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["JQ2023H004"],"award-info":[{"award-number":["JQ2023H004"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82322048"],"award-info":[{"award-number":["82322048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272872"],"award-info":[{"award-number":["82272872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.compbiomed.2024.108537","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T05:44:24Z","timestamp":1714369464000},"page":"108537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Proteomic, single-cell and bulk transcriptomic analysis of plasma and tumor tissues unveil core proteins in response to anti-PD-L1 immunotherapy in triple negative breast cancer"],"prefix":"10.1016","volume":"176","author":[{"given":"Yingpu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-nan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9266-3834","authenticated-orcid":false,"given":"He","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9234-1328","authenticated-orcid":false,"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2024.108537_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100907","article-title":"Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1\/PD-L1 blockade","volume":"66","author":"Pang","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"7528","key":"10.1016\/j.compbiomed.2024.108537_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.compbiomed.2024.108537_bib3","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1038\/s41591-022-01977-y","article-title":"Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial","volume":"28","author":"Gogishvili","year":"2022","journal-title":"Nat. Med."},{"issue":"10336","key":"10.1016\/j.compbiomed.2024.108537_bib4","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0140-6736(22)00562-1","article-title":"Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial","volume":"399","author":"Luke","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108537_bib5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1470-2045(19)30689-8","article-title":"Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"21","author":"Schmid","year":"2020","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.compbiomed.2024.108537_bib7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.annonc.2021.05.801","article-title":"Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced\/metastatic triple-negative breast cancer","volume":"32","author":"Miles","year":"2021","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.compbiomed.2024.108537_bib8","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","article-title":"Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer","volume":"39","author":"Zhang","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.compbiomed.2024.108537_bib10","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1158\/1078-0432.CCR-20-4226","article-title":"Molecular features of cancer-associated fibroblast subtypes and their implication on cancer pathogenesis, prognosis, and immunotherapy resistance","volume":"27","author":"Galbo","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108537_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discov"},{"issue":"4","key":"10.1016\/j.compbiomed.2024.108537_bib13","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in alphaSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib14","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","article-title":"Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment","volume":"13","author":"Luo","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108537_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004582","article-title":"Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade","volume":"10","author":"Harel","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000204","article-title":"In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma","volume":"8","author":"Babacic","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"11","key":"10.1016\/j.compbiomed.2024.108537_bib17","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.annonc.2021.08.1748","article-title":"Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance","volume":"32","author":"Loriot","year":"2021","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib18","first-page":"60","article-title":"Discovery of efficacy biomarkers for non-small cell lung cancer with first-line anti-PD-1 immunotherapy by data-independent acquisition mass spectrometry","volume":"208","author":"Chao","year":"2022","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.compbiomed.2024.108537_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/procel\/pwad004","article-title":"Longitudinal proteomic investigation of COVID-19 vaccination","volume":"14","author":"Wang","year":"2023","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108537_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110271","article-title":"Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19","volume":"38","author":"Bi","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and metabolomic characterization of COVID-19 patient sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.compbiomed.2024.108537_bib22","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/j.jmb.2020.01.027","article-title":"SSizer: determining the sample sufficiency for comparative biological study","volume":"432","author":"Li","year":"2020","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108537_bib23","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1074\/mcp.TIR119.001646","article-title":"DEqMS: a method for accurate variance estimation in differential protein expression analysis","volume":"19","author":"Zhu","year":"2020","journal-title":"Mol. Cell. Proteomics"},{"issue":"12","key":"10.1016\/j.compbiomed.2024.108537_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108537_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C5MB00663E","article-title":"ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization","volume":"12","author":"Yu","year":"2016","journal-title":"Mol. Biosyst."},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108537_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108537_bib27","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.6026\/97320630002005","article-title":"Mfuzz: a software package for soft clustering of microarray data","volume":"2","author":"Kumar","year":"2007","journal-title":"Bioinformation"},{"issue":"9","key":"10.1016\/j.compbiomed.2024.108537_bib29","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.compbiomed.2024.108537_bib30","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020107333","article-title":"A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast","volume":"40","author":"Pal","year":"2021","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.compbiomed.2024.108537_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"15","key":"10.1016\/j.compbiomed.2024.108537_bib32","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1093\/nar\/gkab638","article-title":"CellCall: integrating paired ligand-receptor and transcription factor activities for cell-cell communication","volume":"49","author":"Zhang","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"7693","key":"10.1016\/j.compbiomed.2024.108537_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108537_bib34","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","article-title":"Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma","volume":"26","author":"Braun","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib35","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.compbiomed.2024.108537_bib36","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","article-title":"Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2024.108537_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687975","article-title":"IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and Signatures","volume":"12","author":"Zeng","year":"2021","journal-title":"Front. Immunol."},{"issue":"D1","key":"10.1016\/j.compbiomed.2024.108537_bib38","doi-asserted-by":"crossref","first-page":"D1288","DOI":"10.1093\/nar\/gkac813","article-title":"DrugMAP: molecular atlas and pharma-information of all drugs","volume":"51","author":"Li","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.compbiomed.2024.108537_bib39","doi-asserted-by":"crossref","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: therapeutic Target Database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108537_bib40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/1078-0432.CCR-16-3001","article-title":"Breast cancer immunotherapy: facts and hopes","volume":"24","author":"Emens","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.compbiomed.2024.108537_bib41","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1158\/1078-0432.CCR-19-0137","article-title":"Sex hormones and anticancer immunity","volume":"25","author":"Ozdemir","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108537_bib42","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1158\/1078-0432.CCR-19-3249","article-title":"Investigation of antigen-specific T-cell receptor clusters in human cancers","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"43","key":"10.1016\/j.compbiomed.2024.108537_bib43","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.compbiomed.2024.108537_bib44","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1158\/0008-5472.CAN-20-2000","article-title":"Inflammation and apolipoproteins are potential biomarkers for stratification of cutaneous melanoma patients for immunotherapy and targeted therapy","volume":"81","author":"Karlsson","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2024.108537_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102463","article-title":"Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing","volume":"56","author":"Hao","year":"2022","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.compbiomed.2024.108537_bib46","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov."},{"issue":"14","key":"10.1016\/j.compbiomed.2024.108537_bib47","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res."},{"issue":"6005","key":"10.1016\/j.compbiomed.2024.108537_bib48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12929-022-00790-6","article-title":"LRG1: an emerging player in disease pathogenesis","volume":"29","author":"Camilli","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2016.11.007","article-title":"Reconstruction of LPS transfer cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer","volume":"46","author":"Ryu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.compbiomed.2024.108537_bib51","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","article-title":"S100A8\/A9 in inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.compbiomed.2024.108537_bib52","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/sj.onc.1207323","article-title":"Immunological and pathobiological roles of fibulin-1 in breast cancer","volume":"23","author":"Pupa","year":"2004","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.compbiomed.2024.108537_bib53","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.7150\/thno.82898","article-title":"Induction of ER stress-mediated apoptosis through SOD1 upregulation by deficiency of CHI3L1 inhibits lung metastasis","volume":"13","author":"Yu","year":"2023","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108537_bib54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","article-title":"Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies","volume":"18","author":"Beers","year":"2019","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.compbiomed.2024.108537_bib55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccell.2018.09.003","article-title":"Complement C5a fosters squamous carcinogenesis and limits T cell response to chemotherapy","volume":"34","author":"Medler","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib56","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/s41467-022-33598-x","article-title":"Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer","volume":"13","author":"Monteran","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib57","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41467-019-08831-9","article-title":"An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics","volume":"10","author":"Angelidis","year":"2019","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.compbiomed.2024.108537_bib58","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/CIRCULATIONAHA.119.045158","article-title":"Prioritizing candidates of post-myocardial infarction heart failure using plasma proteomics and single-cell transcriptomics","volume":"142","author":"Chan","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.compbiomed.2024.108537_bib59","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138345","article-title":"Integrated urine proteomics and renal single-cell genomics identify an IFN-gamma response gradient in lupus nephritis","volume":"5","author":"Fava","year":"2020","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib60","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","article-title":"Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.compbiomed.2024.108537_bib61","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","article-title":"Cancer-associated fibroblasts in the single-cell era","volume":"3","author":"Lavie","year":"2022","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.compbiomed.2024.108537_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216095","article-title":"PLA2G2A(+) cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8(+) cytotoxic T cells","volume":"558","author":"Ge","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib63","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1038\/s41467-022-34581-2","article-title":"Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108537_bib64","doi-asserted-by":"crossref","first-page":"C415","DOI":"10.1152\/ajpcell.00517.2020","article-title":"LRG1 facilitates corneal fibrotic response by inducing neutrophil chemotaxis via Stat3 signaling in alkali-burned mouse corneas","volume":"321","author":"Yu","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108537_bib65","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.kint.2021.10.023","article-title":"Modulation of transforming growth factor-beta-induced kidney fibrosis by leucine-rich \u237a-2 glycoprotein-1","volume":"101","author":"Hong","year":"2022","journal-title":"Kidney Int."},{"issue":"7458","key":"10.1016\/j.compbiomed.2024.108537_bib66","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature12345","article-title":"LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling","volume":"499","author":"Wang","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.compbiomed.2024.108537_bib67","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1681\/ASN.2018060599","article-title":"LRG1 promotes diabetic kidney disease progression by enhancing TGF-beta-induced angiogenesis","volume":"30","author":"Hong","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"15","key":"10.1016\/j.compbiomed.2024.108537_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512445","article-title":"LRG1 promotes ECM integrity by activating the TGF-beta signaling pathway in fibroblasts","volume":"24","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108537_bib69","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","author":"Afshar-Kharghan","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108537_bib70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12016-019-08741-0","article-title":"Complement system: a neglected pathway in immunotherapy","volume":"58","author":"Bordron","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.compbiomed.2024.108537_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041026","article-title":"The receptor for advanced glycation endproducts (RAGE) and its ligands S100a8\/A9 and high mobility group Box protein 1 (HMGB1) are key regulators of myeloid-derived suppressor cells","volume":"15","author":"Ostrand-Rosenberg","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108537_bib72","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s40425-019-0828-1","article-title":"Tumor microenvironment-derived S100A8\/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies","volume":"7","author":"Wagner","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.compbiomed.2024.108537_bib73","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482524006218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482524006218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T04:17:21Z","timestamp":1728274641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482524006218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":73,"alternative-id":["S0010482524006218"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108537","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic, single-cell and bulk transcriptomic analysis of plasma and tumor tissues unveil core proteins in response to anti-PD-L1 immunotherapy in triple negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108537"}}